Aspartate Aminotransferase acc. to IFCC II 08104719190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 07613336130537), received between Nov 7, 2024 and Oct 15, 2025 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results2
- Non Reproducible Results2
- Incorrect, Inadequate or Imprecise Result or Readings1
- Unable to Obtain Readings1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 15, 2025Unable to Obtain Readings; Incorrect, Inadequate or Imprecise Result or Readings; Unable to Obtain Readings; Incorrect, Inadequate or Imprecise Result or Readings
THERE WAS AN ALLEGATION OF QUESTIONABLE ASPARTATE AMINO TRANSFERASE AND ALTP GEN.2 RESULTS FOR ONE PATIENT FROM THE COBAS C 503 ANALYTICAL UNIT. THE CUSTOMER SUSPECTED THAT AN INTERFERENCE FROM THE PATIENT¿S MEDICATION WAS CAUSING INCORRECT RESULTS AND DATA FLAGS. THE MEDWATCH IS FOR THE ASPARTATE AMINO TRANSFERASE ASSAY. REFER TO THE MEDWATCH WITH A1-PATIENT IDENTIFIER (B)(6) FOR THE ALTP GEN.2 ASSAY. THE INITIAL RESULTS HAD ">KIN3" DATA FLAGS. AFTER THE INITIAL RESULTS, THE CUSTOMER RETESTED THE SAMPLE WITH VARIOUS DILUTIONS. THE CUSTOMER COULD NOT PROVIDE SPECIFIC DATA BUT STATED ALL OF THE RESULTS WERE ACCOMPANIED BY THE DATA FLAG. THE CUSTOMER RETESTED THE PATIENT SAMPLE AS IF IT WERE QC MATERIAL. THE ALT RESULT WAS -7.35 U/L WITH A DATA FLAG. THE AST RESULT WAS 4.07 U/L WITH A DATA FLAG. A NEW SAMPLE WAS COLLECTED FROM THE PATIENT, AND THE RESULTS WERE THE SAME, WITH THE DATA FLAG. NO SPECIFIC DATA WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23281728 ↗MalfunctionMay 2, 2025Low Test Results; Low Test Results
THERE WAS AN ALLEGATION OF QUESTIONABLE ALTP GEN.2 (ALT) AND ASPARTATE AMINO TRANSFERASE (AST) RESULTS FOR 1 PATIENT SAMPLE ON A COBAS C 303 ANALYTICAL UNIT. THE INITIAL ALT AND AST RESULTS PRODUCED DATA FLAGS. IT WAS REPORTED THAT THE REPEATED RESULTS CONFIRMED THE ISSUE WAS "SAMPLE SPECIFIC". AN INTERFERENCE BETWEEN THE ASSAYS AND THE PATIENT SAMPLE WAS SUSPECTED. THE NUMERICAL RESULTS WERE NOT PROVIDED. THIS MEDWATCH WILL APPLY TO THE ASPARTATE AMINO TRANSFERASE ASSAY. PLEASE REFER TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE ALTP GEN.2 ASSAY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21949322 ↗MalfunctionApr 18, 2025Low Test Results; Low Test Results
ROCHE DIAGNOSTICS RECEIVED A CUSTOMER COMPLAINT REGARDING ALLEGED NON-REPRODUCIBLE ASTP2 ASSAY RESULTS FOR ONE PATIENT SAMPLE TESTED ON A COBAS C 503 ANALYTICAL UNIT. THE SAMPLE INITIALLY RESULTED IN AN AST VALUE OF 19.4 U/L. THE SAMPLE WAS REPEATED, BUT IT RESULTED IN NO VALUE, ONLY A FLAG INDICATING A REACTION ISSUE. THE SAMPLE WAS DILUTED 1:20 AND REPEATED, RESULTING IN AN AST VALUE OF 3934 U/L. THE SAMPLE WAS REPEATED TWO ADDITIONAL TIMES ON (B)(6) 2025, BUT EACH TIME IT DID NOT RESULT IN A VALUE, ONLY A FLAG INDICATING A REACTION ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21865197 ↗MalfunctionApr 1, 2025Non Reproducible Results; Non Reproducible Results
THERE WAS AN ALLEGATION OF QUESTIONABLE ASPARTATE AMINO TRANSFERASE RESULTS FROM THE COBAS C 503 ANALYTICAL UNIT. THE INITIAL RESULT WAS 6.18 U/L. THE REPEAT RESULT WITH A 1:20 DILUTION WAS 3772 U/L WITH A DATA FLAG. THE NEXT DAY THE RESULT FROM A NEW SAMPLE HAD A HIGH RESULT ACCOMPANIED BY A DATA FLAG. NO SPECIFIC DATA WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21741562 ↗MalfunctionNov 7, 2024Non Reproducible Results; Non Reproducible Results
THERE WAS AN ALLEGATION OF QUESTIONABLE ASPARTATE AMINO TRANSFERASE RESULTS FOR 1 PATIENT ON A COBAS C 503 ANALYTICAL UNIT. THE INITIAL RESULT WAS 923 U/L. THE PATIENT WAS SUSPECTED OF HAVING A NEUROMUSCULAR PATHOLOGY BUT WITHOUT THE ALTERATION OF THE OTHER RHABDOMYOLYSIS PARAMETERS. THE SAMPLE WAS REPEATED ON ANOTHER MODULE AND THE RESULT WAS 145 U/L. A NEW SAMPLE WAS OBTAINED AND THE RESULT WAS 967 U/L. THE SAMPLE WAS AUTOMATICALLY REPEATED WITH A 1:10 DILUTION AND THE RESULT WAS 974 U/L. REPEAT TESTING WAS PERFORMED DUE TO THE INITIAL RESULTS NOT MATCHING THE PATIENT'S CLINICAL STATUS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20633453 ↗
Other Nadh oxidation/nad reduction, ast/sgot devices
- Aspartate Aminotransferase acc to IFCC without pyridoxal phosphate activation 20764949322Roche Diagnostics GmbH · Nadh oxidation/nad reduction, ast/sgot6 reports
- Aspartate Aminotransferase acc to IFCC without pyridoxal phosphate activation 5850819190Roche Diagnostics GmbH · Nadh oxidation/nad reduction, ast/sgot4 reports
- Aspartate Aminosransferase acc. to IFCC with pyridoxal phosphate activation 08056838190Roche Diagnostics GmbH · Nadh oxidation/nad reduction, ast/sgot4 reports
- Aspartate Aminotransferase acc to IFCC with pyridoxal phosphate activation 4467493190Roche Diagnostics GmbH · Nadh oxidation/nad reduction, ast/sgot3 reports
- Piccolo AmLyte 13 400-0041Abaxis, Inc. · Nadh Oxidation/Nad Reduction, Ast/Sgot1 report
- ARCHITECT 7D81-22Abbott GmbH · Nadh oxidation/nad reduction, ast/sgot1 report
- Piccolo General Chemistry 13 400-0029Abaxis, Inc. · Nadh Oxidation/Nad Reduction, Ast/Sgot1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page